Latest news
LTR Pharma Achieves 93% Response Rate in 147-Patient Real-World SPONTAN® Study - kalkinemedia.comkalkinemedia.com · Mon, 10 Aug 2026 23:15:02 GMTMicot Pharma's MT200605 Achieves Primary Endpoint in Phase II Trial, Novel Integrated Multi-stage Neuroprotection Mechanism to Be Presented at WSC 2026 - FinancialContentFinancialContent · Fri, 07 Aug 2026 08:36:00 GMTAnlon Healthcare Achieves Triple-Digit Growth in Q1 FY27, Strengthens Integrated Pharma Platform - ThePrintThePrint · Sat, 01 Aug 2026 08:30:09 GMTSGD Pharma accelerates sustainable transformation - Packaging South AsiaPackaging South Asia · Thu, 30 Jul 2026 07:00:00 GMT